REPL logo

REPLReplimune Group Inc

$8.88
$0.26
(3.02%)
Today
Closed $8.88
$0.05
(0.56%)
After Hours
Updated: 07:50 PM EDT
EarningsJun 15
Mkt Cap$733.24M
Vol1.97M
35

Bearish Sentiment

How do you feel about REPL?

About

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
479

Frequently Asked Questions

What is Market Cap of Replimune Group Inc?
What is the 52-week high for Replimune Group Inc?
What is the 52-week low for Replimune Group Inc?
What is Replimune Group Inc stock price today?
What was Replimune Group Inc stock price yesterday?
What is the PE ratio of Replimune Group Inc?
What is the Price-to-Book ratio of Replimune Group Inc?
What is the 50-day moving average of Replimune Group Inc?
How many employees does Replimune Group Inc have?

Advertisement|Remove ads.